NCT06952296View on ClinicalTrials.gov

Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-related Pain

Not yet recruitingOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Endometriosis

Interventions

DRUG

Dydrogesterone

"The duration of treatment with dydrogesterone is determined by the physician before inclusion in the study and will last for 6 menstrual cycles (Cycle used in the protocol refers to menstrual cycle. 1 cycle is 28 days on average)"